Sutro Biopharma (STRO) — Cash Flow Reinvestment Rate
Sutro Biopharma (STRO) has a Cash Flow Reinvestment Rate of 8.58x as of June 2024, reinvesting $81.13 Million (capex $756.00K plus investments $-80.38 Million) from operating cash flow of $9.46 Million. See Sutro Biopharma free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sutro Biopharma Cash Flow Reinvestment Rate (2018–2022)
Historical reinvestment intensity for Sutro Biopharma across 2 annual periods. For the full cash flow conversion analysis, see Sutro Biopharma cash conversion from operations.
Annual Cash Flow Reinvestment Rate for Sutro Biopharma (2018–2022)
Year-by-year capital reinvestment analysis for Sutro Biopharma. See Sutro Biopharma leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 12.08x | $42.88 Million | $3.55 Million | $7.86 Million | ▲ +90.9% |
| 2018 | 6.33x | $80.27 Million | $12.68 Million | $1.56 Million | — |